Inventor
LUZZIO MICHAEL JOSEPH
US32 patents
⚠️ This page may combine multiple inventors who share the name “LUZZIO MICHAEL JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
12 patentsUS7928109B2Apr 19, 2011
Sulfonyl amide derivatives for the treatment of abnormal cell growth
PFIZER36 citations94
US7741336B2Jun 22, 2010
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER18 citations92
US7351712B2Apr 1, 2008
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER19 citations92
US7235562B2Jun 26, 2007
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER34 citations92
US7208499B2Apr 24, 2007
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER27 citations92
US7109335B2Sep 19, 2006
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER25 citations92
US7109337B2Sep 19, 2006
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER33 citations92
US7122670B2Oct 17, 2006
Selective synthesis of CF3-substituted pyrimidines
PFIZER21 citations91
US7145008B2Dec 5, 2006
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER21 citations84
US6964961B2Nov 15, 2005
Thiophene derivatives useful as anticancer agents
PFIZER17 citations84
US7674796B2Mar 9, 2010
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER4 citations74
US7820648B2Oct 26, 2010
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER2 citations45
GLAXO WELLCOME INC
4 patentsUS6387919B1May 14, 2002
Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
GLAXO WELLCOME INC34 citations90
US6100273AAug 8, 2000
Water soluble camptothecin derivatives
GLAXO WELLCOME INC22 citations87
US6172064B1Jan 9, 2001
Formamides as therapeutic agents
GLAXO WELLCOME INC12 citations71
US6090825AJul 18, 2000
Oxazole derivatives as antagonists of alpha 1C andrenergic receptors
GLAXO WELLCOME INC10 citations71
NOVARTIS AG
4 patentsUS9845309B2Dec 19, 2017
Protein kinase C inhibitors and methods of their use
NOVARTIS AG6 citations83
US11505541B2Nov 22, 2022
Protein kinase C inhibitors and methods of their use
NOVARTIS AG1 citations72
US11059804B2Jul 13, 2021
Protein kinase C inhibitors and methods of their use
NOVARTIS AG3 citations72
US10508101B2Dec 17, 2019
Protein kinase C inhibitors and methods of their use
NOVARTIS AG3 citations72
SMITHKLINE BEECHAM CORP
3 patentsUS6369086B1Apr 9, 2002
Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors
SMITHKLINE BEECHAM CORP213 citations98
US7105529B2Sep 12, 2006
Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
SMITHKLINE BEECHAM CORP64 citations97
US6541503B2Apr 1, 2003
Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
SMITHKLINE BEECHAM CORP22 citations92
EDGEWISE THERAPEUTICS INC
3 patentsUS12559464B2Feb 24, 2026
Quinazolinone dione compounds and uses thereof
EDGEWISE THERAPEUTICS INC0 citations44
US12448369B2Oct 21, 2025
Quinolinone amide compounds and uses thereof
EDGEWISE THERAPEUTICS INC0 citations44
US12509431B2Dec 30, 2025
1,4-dihydroquinazolinone compounds and uses thereof
EDGEWISE THERAPEUTICS INC0 citations43